- Home
- UONEK vs PULM Comparison
UONEK vs PULM Comparison
Compare UONEK & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONEK
- PULM
- Stock Information
- Founded
- UONEK 1980
- PULM 2003
- Country
- UONEK United States
- PULM United States
- Employees
- UONEK 1396
- PULM N/A
- Industry
- UONEK Broadcasting
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- UONEK Consumer Discretionary
- PULM Health Care
- Exchange
- UONEK Nasdaq
- PULM Nasdaq
- Market Cap
- UONEK 28.1M
- PULM 33.2M
- IPO Year
- UONEK N/A
- PULM N/A
- Fundamental
- Price
- UONEK $0.59
- PULM $6.41
- Analyst Decision
- UONEK
- PULM
- Analyst Count
- UONEK 0
- PULM 0
- Target Price
- UONEK N/A
- PULM N/A
- AVG Volume (30 Days)
- UONEK 250.7K
- PULM 57.4K
- Earning Date
- UONEK 08-07-2025
- PULM 08-12-2025
- Dividend Yield
- UONEK N/A
- PULM N/A
- EPS Growth
- UONEK N/A
- PULM N/A
- EPS
- UONEK N/A
- PULM N/A
- Revenue
- UONEK $437,499,000.00
- PULM $1,921,000.00
- Revenue This Year
- UONEK N/A
- PULM N/A
- Revenue Next Year
- UONEK N/A
- PULM $134.88
- P/E Ratio
- UONEK N/A
- PULM N/A
- Revenue Growth
- UONEK N/A
- PULM N/A
- 52 Week Low
- UONEK $0.44
- PULM $1.78
- 52 Week High
- UONEK $1.57
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- UONEK 45.73
- PULM 37.18
- Support Level
- UONEK $0.55
- PULM $6.28
- Resistance Level
- UONEK $0.99
- PULM $6.83
- Average True Range (ATR)
- UONEK 0.15
- PULM 0.35
- MACD
- UONEK -0.01
- PULM -0.07
- Stochastic Oscillator
- UONEK 5.85
- PULM 0.00
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).